Beck Mack & Oliver LLC Decreases Position in Mettler-Toledo International, Inc. $MTD

Key Points

• Beck Mack & Oliver LLC has decreased its stake in Mettler-Toledo International by 22.5%, holding 690 shares worth $815,000 after selling 200 shares in the first quarter.
• Significant increases in shareholding were noted from other institutional investors, including GAMMA Investing LLC, which increased its position by 131,246.3% to own 386,158 shares valued at approximately $456 million.
• Analysts have issued mixed ratings on Mettler-Toledo, with five giving it a buy rating and five a hold rating, alongside a consensus target price of $1,311.11.

Beck Mack & Oliver LLC reduced its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 22.5% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 690 shares of the medical instruments supplier's stock after selling 200 shares during the quarter. Beck Mack & Oliver LLC's holdings in Mettler-Toledo International were worth $815,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. GAMMA Investing LLC lifted its position in shares of Mettler-Toledo International by 131,246.3% during the first quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier's stock worth $456,018,000 after purchasing an additional 385,864 shares in the last quarter. Nuveen LLC acquired a new position in Mettler-Toledo International in the 1st quarter worth $71,897,000. AustralianSuper Pty Ltd boosted its position in Mettler-Toledo International by 60.4% in the 1st quarter. AustralianSuper Pty Ltd now owns 114,986 shares of the medical instruments supplier's stock valued at $135,788,000 after buying an additional 43,313 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its stake in shares of Mettler-Toledo International by 11.9% during the first quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier's stock valued at $479,673,000 after acquiring an additional 43,082 shares in the last quarter. Finally, Millennium Management LLC increased its position in shares of Mettler-Toledo International by 2,411.4% during the fourth quarter. Millennium Management LLC now owns 43,346 shares of the medical instruments supplier's stock worth $53,042,000 after acquiring an additional 41,620 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company's stock.

Insider Transactions at Mettler-Toledo International

In related news, insider Gerry Keller sold 165 shares of the stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total value of $215,925.60. Following the sale, the insider owned 94 shares of the company's stock, valued at $123,012.16. This trade represents a 63.71% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Shawn Vadala sold 300 shares of the business's stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total transaction of $376,227.00. Following the transaction, the chief financial officer directly owned 5,095 shares of the company's stock, valued at $6,389,588.55. The trade was a 5.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 1,827 shares of company stock worth $2,371,208. Insiders own 1.94% of the company's stock.

Analysts Set New Price Targets

A number of research analysts recently commented on MTD shares. UBS Group raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and reduced their price target for the company from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Barclays assumed coverage on shares of Mettler-Toledo International in a research report on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 price target for the company. Wells Fargo & Company increased their price objective on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a research note on Monday, May 5th. Citigroup raised their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a report on Thursday, August 21st. Finally, Evercore ISI cut their target price on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating on the stock in a research note on Monday, August 4th. Five analysts have rated the stock with a Buy rating and five have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $1,311.11.

Mettler-Toledo International Stock Up 1.5%

MTD opened at $1,302.74 on Friday. The company's 50-day moving average price is $1,240.96 and its 200 day moving average price is $1,185.95. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,521.01. The firm has a market cap of $26.84 billion, a price-to-earnings ratio of 32.99, a price-to-earnings-growth ratio of 3.90 and a beta of 1.34.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The company had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. During the same period in the prior year, the company earned $9.65 earnings per share. The business's revenue was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.